Next Article in Journal
Does an Adolescent’s Accuracy of Recall Improve with a Second 24-h Dietary Recall?
Next Article in Special Issue
Selenium and Chronic Diseases: A Nutritional Genomics Perspective
Previous Article in Journal
Suboptimal Micronutrient Intake among Children in Europe
Previous Article in Special Issue
Low Folate and Selenium in the Mouse Maternal Diet Alters Liver Gene Expression Patterns in the Offspring after Weaning
Article Menu

Export Article

Open AccessReview
Nutrients 2015, 7(5), 3536-3556; doi:10.3390/nu7053536

Redox-Active Selenium Compounds—From Toxicity and Cell Death to Cancer Treatment

1
Division of Pathology F46, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm 141 86, Sweden
2
Department of Nutritional Sciences, College of Human Sciences, Texas Tech University, P.O. Box 41270, Lubbock, TX 79409-1270, USA
*
Author to whom correspondence should be addressed.
Received: 28 March 2015 / Revised: 24 April 2015 / Accepted: 5 May 2015 / Published: 13 May 2015
(This article belongs to the Special Issue Dietary Selenium and Human Health)
View Full-Text   |   Download PDF [536 KB, uploaded 13 May 2015]   |  

Abstract

Selenium is generally known as an antioxidant due to its presence in selenoproteins as selenocysteine, but it is also toxic. The toxic effects of selenium are, however, strictly concentration and chemical species dependent. One class of selenium compounds is a potent inhibitor of cell growth with remarkable tumor specificity. These redox active compounds are pro-oxidative and highly cytotoxic to tumor cells and are promising candidates to be used in chemotherapy against cancer. Herein we elaborate upon the major forms of dietary selenium compounds, their metabolic pathways, and their antioxidant and pro-oxidant potentials with emphasis on cytotoxic mechanisms. Relative cytotoxicity of inorganic selenite and organic selenocystine compounds to different cancer cells are presented as evidence to our perspective. Furthermore, new novel classes of selenium compounds specifically designed to target tumor cells are presented and the potential of selenium in modern oncology is extensively discussed. View Full-Text
Keywords: selenium; antioxidants; selenoproteins; cancer; tumor; cytotoxicity selenium; antioxidants; selenoproteins; cancer; tumor; cytotoxicity
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Misra, S.; Boylan, M.; Selvam, A.; Spallholz, J.E.; Björnstedt, M. Redox-Active Selenium Compounds—From Toxicity and Cell Death to Cancer Treatment. Nutrients 2015, 7, 3536-3556.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top